Medable is the developer of a cloud-based platform designed to deliver effective therapies to patients worldwide. Medable's platform encompasses modules such as back-end, analytics, collaboration, compliance, and research survey, all tailored to the strict compliance, interoperability, and privacy concerns of the global healthcare sector. This enables medical practitioners to simplify digital trials, expanding patient access and improving outcomes.

Investors Include:

ACVC Partners, Emerson Collective, National Cancer Institute, Launchpad Digital Health, Sapphire Ventures, PROOF, GSR Ventures China, Tiger Global Management, Blackstone, Business Association of Stanford Entrepreneurial Students, Obvious Ventures, Western Technology Investment, Springboard Enterprises, Loren McFarland, MedTech Innovator, Steve Wang, Texas Medical Center, Pharmaceutical Product Development, Streamlined Ventures, Connectivity Ventures Fund, Anula Jayasuriya, North Sky Capital, Ullas Naik.

Collective explained in 2 minutes

Learn how Collective's solutions enable you to manage your risk and maximize your wealth

Learn more

Our available services for this company

Lifetime IncomeCharitable Remainder Trust

Tax SavingsDonor Advised Fund